Valuation Trading Multiples & Precedent Transactions: Diabetes Care Device Companies
Valuation benchmarks for Diabetes Care Device Companies. Access public trading comps, EV/EBITDA acquisition multiples, and private market data for pitch books and valuation analysis.
1.1 - Diabetes Care Device Companies Market Context & Valuation Drivers
Companies in this public trading comparables group design, manufacture, and market diabetes care devices, including insulin delivery systems and glucose monitoring technologies. Business models blend durable hardware, consumable supplies, and connected software, creating recurring revenue streams. They are comparable for valuation because they target similar end markets, rely on reimbursement-driven adoption, and monetize installed bases through disposables and digital services.
Typical capabilities include tubed and tubeless insulin pumps, automated insulin delivery algorithms integrated with CGM, implantable and wearable continuous glucose monitoring systems, infusion sets and cannulas, autoinjectors and pen injectors, mobile apps for remote monitoring and dose tracking, cloud data platforms and interoperability with third‑party sensors, and patient training, technical support, and reimbursement assistance that enhance adoption and lifetime value.
Primary customers include diabetes patients through DME and pharmacy channels, endocrinology clinics and diabetes educators, and hospitals and ambulatory care providers, with payers influencing reimbursement. Key valuation benchmarks include installed base growth, recurring consumables and subscription revenue, gross margin profile, sensor and pump attach rates, retention and upgrade cycles, regulatory and reimbursement coverage, and geographic mix driving revenue growth.
2. Valuation Analysis: Public Trading Comps & Multiples for Diabetes Care Device Companies companies
2.1 - Public Peer Groups & Median Valuation Multiples for Diabetes Care Device Companies sector
Comparable group 1: Diabetes Care Device Companies
Ypsomed
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of injection and infusion systems for self-medication, specializing in solutions for diabetes care and other therapeutic areas. The company designs, develops, and manufactures devices aimed at improving patient wellbeing through innovative and user-friendly technology.
- Key Products:
- Insulin Pumps: Advanced insulin pumps designed for ease of use and precise diabetes management
- Autoinjectors: User-friendly autoinjectors for the convenient administration of liquid medications
- Pen Injectors: Reliable pen injectors enabling patients to self-administer injections with accuracy
- Digital Health Solutions: Integrated digital tools and apps for therapy management and patient support
- Infusion Sets: High-quality infusion sets optimized for continuous subcutaneous insulin infusion.
ConvaTec Group
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of medical products and technologies for chronic conditions, specializing in advanced wound care, ostomy care, continence care, and infusion care, offering solutions focused on improving patient outcomes and enhancing quality of life.
- Key Products:
- Ostomy Care: Wide range of ostomy products and accessories designed for different types of stomas
- Advanced Wound Care: Solutions for management of chronic wounds including dressings and skin barriers
- Continence & Critical Care: Products for managing continence and critical care needs
- Infusion Care: Comprehensive infusion sets and systems for diabetes and other conditions
- Wound Care: Advanced solutions for chronic and acute wound management.